BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stefanovic V. The Extended Use of Eculizumab in Pregnancy and Complement Activation⁻Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now? J Clin Med 2019;8:E407. [PMID: 30909646 DOI: 10.3390/jcm8030407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report. Am J Case Rep 2019;20:1460-5. [PMID: 31582717 DOI: 10.12659/AJCR.916994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Massey JM, Gable KL. Neuromuscular Disorders and Pregnancy. CONTINUUM: Lifelong Learning in Neurology 2022;28:55-71. [DOI: 10.1212/con.0000000000001069] [Reference Citation Analysis]
3 Wijnsma KL, Ter Heine R, Wetzels JFM, van de Kar NCAJ, Brüggemann RJ. Author's Reply to Liu et al.: "Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab". Clin Pharmacokinet 2020;59:1645-6. [PMID: 33118148 DOI: 10.1007/s40262-020-00952-5] [Reference Citation Analysis]
4 Cohen H, Cuadrado MJ, Erkan D, Duarte-Garcia A, Isenberg DA, Knight JS, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Williams DJ, Willis R, Woller SC, Andrade D. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus 2020;29:1571-93. [PMID: 33100166 DOI: 10.1177/0961203320950461] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
5 Minuth WW. Shaping of the nephron - a complex, vulnerable, and poorly explored backdrop for noxae impairing nephrogenesis in the fetal human kidney. Mol Cell Pediatr 2020;7:2. [PMID: 31965387 DOI: 10.1186/s40348-020-0094-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Puri P, Hanxhiu A, O'Hara DV, Hsu D, Vucak-Dzumhur M. A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab. BMC Nephrol 2020;21:488. [PMID: 33203373 DOI: 10.1186/s12882-020-02100-4] [Reference Citation Analysis]
7 Lung T, Sakem B, Risch L, Würzner R, Colucci G, Cerny A, Nydegger U. The complement system in liver diseases: Evidence-based approach and therapeutic options. J Transl Autoimmun 2019;2:100017. [PMID: 32743505 DOI: 10.1016/j.jtauto.2019.100017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Lewandowska M, Englert-golon M, Krasiński Z, Jagodziński PP, Sajdak S. A Rare Case of HELLP Syndrome with Hematomas of Spleen and Liver, Eclampsia, Severe Hypertension and Prolonged Coagulopathy—A Case Report. IJERPH 2022;19:7681. [DOI: 10.3390/ijerph19137681] [Reference Citation Analysis]
9 Fassett MJ, Hernandez Lopez AL. Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report. Case Rep Womens Health 2021;30:e00294. [PMID: 33665137 DOI: 10.1016/j.crwh.2021.e00294] [Reference Citation Analysis]
10 Vasanthamohan L, Choo S, Marshall T, Symons YT, Matsui D, Eastabrook G, Solh Z. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review. Transfusion 2020;60:2448-55. [PMID: 32851670 DOI: 10.1111/trf.16003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Amari Chinchilla K, Vijayan M, Taveras Garcia B, Jim B. Complement-Mediated Disorders in Pregnancy. Adv Chronic Kidney Dis 2020;27:155-64. [PMID: 32553248 DOI: 10.1053/j.ackd.2020.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Morales E, Galindo A, García L, Villalaín C, Alonso M, Gutiérrez E, Rodríguez-Almaraz ME, Praga M, Herraiz I. Eculizumab in Early-Stage Pregnancy. Kidney Int Rep 2020;5:2383-7. [PMID: 33305137 DOI: 10.1016/j.ekir.2020.09.045] [Reference Citation Analysis]
13 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
14 Grover KM, Sripathi N. Myasthenia gravis and pregnancy. Muscle Nerve 2020;62:664-72. [PMID: 32929722 DOI: 10.1002/mus.27064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Caetano R, Rodrigues PHA, Corrêa MCV, Villardi P, Osorio-de-Castro CGS. The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health. Rev Saude Publica 2020;54:22. [PMID: 32130309 DOI: 10.11606/s1518-8787.2020054001693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]